The Annual Sentinel Initiative Public Workshop is a gathering of the Sentinel community and leading experts to share recent developments within the Sentinel Initiative and to promote engagement and collaboration with patients, industry, academia, and consumers. The Duke-Margolis Center for Health Policy hosted the 15th Annual Sentinel Initiative Public Workshop under a cooperative agreement with the Food and Drug Administration (FDA) on November 8, 2023, from 9:00 AM - 5:00 PM ET. The workshop was held as a hybrid event, with in-person and virtual attendance.
The public workshop featured a keynote from Dr. Janet Woodcock, Principal Deputy Commissioner of the FDA. Participants also heard from Sentinel Initiative leadership on a range of key issues, including recent studies and applications of Sentinel to protect and promote public health during the COVID-19 pandemic. Additionally, sessions considered key progress made to fulfill Prescription Drug User Fee Act (PDUFA) commitments, to advance innovation within Sentinel, and to expand and extend important capabilities of the data network.
This event is supported by the Food and Drug Administration (FDA) of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award U01FD006807 totaling $2,575,023 with 100 percent funded by FDA/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by FDA/HHS, or the U.S. Government.
Further event information and materials can be found here.